Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2026-01-01 @ 11:57 PM
Study NCT ID:
NCT04707768
Status:
COMPLETED
Last Update Posted:
2025-01-15
First Post:
2021-01-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects
Sponsor:
Akebia Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-18
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-12
First Submit QC Date:
None
Study First Post Date:
2021-01-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-23
Results First Submit QC Date:
None
Results First Post Date:
2025-01-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-12-18
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-12-23
Last Update Post Date:
2025-01-15
Last Update Post Date Type:
ACTUAL